CoChat

Injectable Hydrogels from Triblock Copolymers of Vitamin E‐Functionalized Polycarbonate and Poly(ethylene glycol) for Subcutaneous Delivery of Antibodies for Cancer Therapy

Lee, Ashlynn L. Z., Ng, Victor W. L., Gao, Shujun, Hedrick, James L., Yang, Yi Yan · 2014 · Advanced Functional Materials
Cited by 99

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

In this study, ‘ABA’‐type triblock copolymers of vitamin E‐functionalized polycarbonate and poly(ethylene glycol), i.e., VitE m‐PEG‐VitE m, with extremely short hydrophobic block VitE m, are synthesized and employed to form physically cross‐linked injectable hydrogels for local and sustained delivery of Herceptin. The hydrogels are formed at low concentrations (4–8 wt%). By varying polymer composition and concentration, the rheological behavior, porosity, and drug release properties of hydrogels are readily tunable. The in vitro antitumor specificity and efficacy of Herceptin in hydrogel and solution are investigated by MTT assay against normal and human breast cancer cell lines with different HER2 expression levels. The results demonstrate that the Herceptin‐loaded hydrogel is specific towards HER2‐overexpressing cancer cells and cytotoxic action is comparable to that of the Herceptin solution. The biocompatibility and biodegradability of hydrogel are evaluated in mice with subcutaneous injection by histological examination. It is observed that the hydrogel does not evoke a chronic inflammatory response and degrades within 6 weeks post administration. Biodistribution and anti‐tumor efficacy studies performed in BT474 tumor‐bearing mice show that single subcutaneous injection of Herceptin‐loaded hydrogel at a site close to the tumor enhances the retention of the antibody within the tumor. This leads to superior anti‐tumor efficacy as compared to intravenous (i.v.) and subcutaneous (s.c.) delivery of Herceptin in solution. The tumor size shrank by 77% at Day 28. When the hydrogel is injected at a distal location away from the tumor site, anti‐tumor efficacy is similar to that of weekly i.v. injections of Herceptin solution over 4 weeks, with the number of injections reduced from 4 to 1. These findings suggest that this hydrogel has great potential for use in subcutaneous and sustained delivery of antibodies to increase therapeutic efficacy and/or improve patient compliance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adfm.201301307

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 99

Metadata

Authors
Lee, A. L. Z., Ng, V. W. L., Gao, S., Hedrick, J. L., & Yang, Y. Y.
Venue
Advanced Functional Materials
Publisher
Wiley
Published
2013-10-31
Volume
24
Issue
11
Pages
1538-1550
ISSN
  • 1616-301X (ISSN-L)
  • 1616-3028
OpenAlex
W2157276138
Cited by
99
References
1
FWCI
3.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Injectable Hydrogels from Triblock Copolymers of Vitamin E‐Functionalized Polycarbonate and Poly(ethylene glycol) for Subcutaneous Delivery of Antibodies for Cancer Therapy. https://app.cochat.ai/papers/10.1002/adfm.201301307
The paper
Lee, A. L. Z., Ng, V. W. L., Gao, S., Hedrick, J. L., & Yang, Y. Y. (2014). Injectable Hydrogels from Triblock Copolymers of Vitamin E‐Functionalized Polycarbonate and Poly(ethylene glycol) for Subcutaneous Delivery of Antibodies for Cancer Therapy. Advanced Functional Materials. https://doi.org/10.1002/adfm.201301307

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.